0000704415-15-000002.txt : 20150126 0000704415-15-000002.hdr.sgml : 20150126 20150126070302 ACCESSION NUMBER: 0000704415-15-000002 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 3 CONFORMED PERIOD OF REPORT: 20150125 ITEM INFORMATION: Other Events ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20150126 DATE AS OF CHANGE: 20150126 FILER: COMPANY DATA: COMPANY CONFORMED NAME: HEALTHWAYS, INC CENTRAL INDEX KEY: 0000704415 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MISC HEALTH & ALLIED SERVICES, NEC [8090] IRS NUMBER: 621117144 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-19364 FILM NUMBER: 15546883 BUSINESS ADDRESS: STREET 1: 701 COOL SPRINGS BOULEVARD CITY: FRANKLIN STATE: TN ZIP: 37067 BUSINESS PHONE: 6156144929 MAIL ADDRESS: STREET 1: 701 COOL SPRINGS BOULEVARD CITY: FRANKLIN STATE: TN ZIP: 37067 FORMER COMPANY: FORMER CONFORMED NAME: AMERICAN HEALTHWAYS INC DATE OF NAME CHANGE: 20000322 FORMER COMPANY: FORMER CONFORMED NAME: AMERICAN HEALTHCORP INC /DE DATE OF NAME CHANGE: 19940211 8-K 1 form8-k_012615.htm HEALTHWAYS, INC. FORM 8-K


UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
___________________

FORM 8‑K


CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934


Date of report (Date of earliest event reported):  January 26, 2015 (January 25, 2015)

HEALTHWAYS, INC.
(Exact name of registrant as specified in its charter)

Delaware
 
000-19364
 
62-1117144
(State or other jurisdiction of incorporation)
 
(Commission
File Number)
 
(IRS Employer
Identification No.)

701 Cool Springs Boulevard
Franklin, Tennessee
 
 
37067
(Address of principal executive offices)
 
(Zip Code)

(615) 614-4929
(Registrant's telephone number, including area code)


(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

    Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
    Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
    Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
    Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))


Item 8.01.  Other Events.
On January 25, 2015, Healthways, Inc. (the "Company") issued a press release stating that its Board of Directors is exploring strategic alternatives. The Company announced that it has retained J.P. Morgan Securities LLC as its financial advisor to assist in its evaluation. The Company further stated that there can be no assurance that the process will result in any specific action and it does not intend to disclose further developments unless and until the Board approves a specific action or otherwise concludes the review of strategic alternatives.

Item 9.01.  Financial Statements and Exhibits.
(d) Exhibits:
   
Exhibit 99.1
 
Press release, dated January 25, 2015.
 
 
 

SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
HEALTHWAYS, INC.
   
   
 
By:
 /s/ Alfred Lumsdaine
   
Alfred Lumsdaine
   
Chief Financial Officer
Date:  January 26, 2015
 
 
 


EXHIBIT INDEX
Exhibit 99.1
 
Press release, dated January 25, 2015





EX-99.1 2 ex991_012615.htm EX. 99-1, PRESS RELEASE, DATED JANUARY 25, 2015

Exhibit 99.1
Investor Relations Contact:
 
Media Relations Contact:
Chip Wochomurka
 
Andrew Cole/Delia Cannan
615-614-4493
 
Sard Verbinnen & Co.
chip.wochomurka@healthways.com
 
212-687-8080
 
 
healthways-svc@sardverb.com
 
 
Healthways Board Exploring Strategic Alternatives to Enhance Shareholder Value
 
Company Remains 100% Focused on Serving its Customers
 
NASHVILLE, Tenn. January 25, 2015 – Healthways, Inc. (NASDAQ: HWAY) ("Company"), the largest independent global provider of well-being improvement solutions, today announced that its Board of Directors is exploring strategic alternatives to enhance shareholder value. The Board has retained J.P. Morgan Securities LLC as its financial advisor to assist in its evaluation of strategic alternatives. While the Board conducts its process, the Company remains 100% focused on serving its customers. There can be no assurance that the Board's process will result in any specific action, and the Company does not intend to disclose further developments unless and until its Board approves a specific action or otherwise concludes the review of strategic alternatives.
 
Forward Looking Statements
This press release contains forward-looking statements, which are based upon current expectations, involve a number of risks and uncertainties and are subject to the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995. Those forward-looking statements include all statements that are not historical statements of fact and those regarding the intent, belief or expectations of the Company, including, without limitation, all statements regarding the Board of Directors review of strategic alternatives. Those forward-looking statements are subject to certain risks and uncertainties, including, but not limited to those risks detailed in the Company's Annual Report on Form 10-K for the fiscal year ended December 31, 2013, and other filings with the Securities and Exchange Commission. The Company undertakes no obligation to update or revise any such forward-looking statements.
 
About Healthways
Healthways is the largest independent global provider of well-being improvement solutions. Dedicated to creating a healthier world one person at a time, the Company uses the science of behavior change to produce and measure positive change in well-being for our customers, which include employers, integrated health systems, hospitals, physicians, health plans, communities and government entities. We provide highly specific and personalized support for each individual and their team of experts to optimize each participant's health and productivity and to reduce health-related costs. Results are achieved by addressing longitudinal health risks and care needs of everyone in a given population. The Company has scaled its proprietary technology infrastructure and delivery capabilities developed over 30 years and now serves approximately 68 million people on four continents. Learn more at www.healthways.com.
 
 
-END-
 

GRAPHIC 3 hwaylogo.jpg begin 644 hwaylogo.jpg M_]C_X``02D9)1@`!`0$`>`!X``#_VP!#``@&!@<&!0@'!P<)"0@*#!0-#`L+ M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#,#`2(``A$!`Q$!_\0` M'P```04!`0$!`0$```````````$"`P0%!@<("0H+_\0`M1```@$#`P($`P4% M!`0```%]`0(#``01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T?`D,V)R@@D* M%A<8&1HE)B7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7& MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0`'P$``P$!`0$! M`0$!`0````````$"`P0%!@<("0H+_\0`M1$``@$"!`0#!`<%!`0``0)W``$" M`Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O`58G+1"A8D-.$E\1<8&1HF M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$ MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4 MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H`#`,!``(1`Q$`/P#W^BBB@`HH MHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB M@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****` M"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`* M***`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`**X+QY\5]!\#J MUL[?;M5QE;.%N5]W;HH_7VKSJSL_B;\6\7%Y?'0/#\GW5C#()%]ESN?ZL0/2 M@#U[6O'_`(4\/DKJ>O644@ZQ*_F./^`KD_I7)3_'WP:KLEJNIWC#H(+7K_WT M15OP]\$O!FAHK3V+:G<`/QK0KQ_ M7?@+IOFF_P#"6IW6B7Z$E`)&:/Z`YW+]&`X:,_W67J#]:UZ`"B MBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`*** M*`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH M`****`"BBB@`KQ?XM_%\Z$\OAWPY*&U3[MS=+R+?/\*^K^_;Z].D^+WC_P#X M0GPUY=G(/[6OLQVP[QC^*3\,@#W/L:\P^!GP_&NZF_BS6(S-:6\I^RK+SYTW M4N<]0OZM]*`.@^%GP="^7XE\7PM/>R'S8+.?YMN>=\N?O,>N#T[\]/P\"^'WU&['FSN=EM;@X,S^GL!U)_KBLOX8Z?JT MVE2^*/$%Q))JNLA9?*)(2W@&?+15Z#@Y]>>>IR?%OXU6=F&9])6X\J M%!T%NGS.WU8*3^(':OJ=5"J%4``<`#M0`M>3_$'4=4^'/B6#QAIYFN=&OG6# M5;)G)4,!A9$S]TD#'ID#/6O6*QO%>AQ>)?"NIZ/*H874#(F>SXRA_!@#^%`% MS2-6LM=TFVU/3YQ-:7*!XW'<>X[$="/6FZQHVG:_IDNG:I:1W5K*,-'(,_B/ M0CL1R*^??@'XQFTKQ!-X1OY"L%TS-;JQ_P!7.OWE]MP!_$#UKZ1H`^7O%'AC MQ#\%O$L>N>'[J2329GVI(W(/?RI@.OL>_;!KW7P#X\T[QYH8O;7$5W%A;JU) MRT3?U4]C_4&M[6-(LM=TFYTS481-:7*%)$/IZCT(Z@]C7RE)_;'P6^)S+$[2 M11$$9X6[MF]??C\&6@#Z[HJCHVK6FNZ/::I82>9:W48DC;V/8^X.0?<5>H`* M***`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HH MHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB M@`I"0`23@"EKEOB/K+:!\/=;OT?9*ML8XF]'?Y%_5J`/F/QOK-U\1OB?(MF3 M)'-<+96*CD!`VT$?4Y;\:^M-!T:U\/:#9:19+BWM(A&OJWJQ]R_:-F>/P'81`_+)J*;OPC?_LZV*7'CZ[NGZVMB[+]6 M95_D37U#7S)^SC)94/J&&1_.OC'XE3KYKWROC+X?7\GA;XIZ6TK$&*]^R38]&)C;^>?PK[-H`****`"BBB@`HHH MH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@ M`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`KR[X_RF/X82 MJ.DEW"I_,G^E>HUYA\?83+\+KAP.(KJ%S^>W_P!FH`X?]FB$'4/$4V.5B@0' MZES_`$%?0]?.W[-,ZKJGB"W+?,\,+@?1F!_]"%?1-`!7E7[0.GF\^&IN%'_' MG>12GZ'*?S<5ZK63XHT5/$?A?4]'D(`N[=HU9AD*V/E/X'!_"@#Y'^%FO)X= M^(VD7DK!8'E^SRD]`L@VY_`D'\*]D_:*U^_T[0-,TNTEDB@U"20W!0XWJ@7" M$^A+9(]J^<;NUN-/O9K2X1HKB"0QR(>"K*<$?F*^D](AT[XX?"^WM;^Y,.M: M>0CS*,M'*!@.1W5QR??/I0!\SQR/#*DD3LDB,&5U."I'0@]C7V+X-\633_"& MT\3:L^Z6&SDDF=N/,\LL,_4[1^)KR>P_9NUEM15=0UJQ2R##<\"NTC#V!``/ MX_G6E\;?$-CX:\*Z?X`T0A%\M#<*IR4B7E5/NQ^8_3WH`\$N[F2]O9[J4YDF MD:1C[DY/\Z^W?!M@^E^"=#L9!B2"QA1QZ,$&?UKY%^'?AM_%7CK3--$>^#S1 M+<\<")#EL_7I]2*^U@,#`Z4`%%%%`'Q7XX4:7\4-;,''DZG)(OUW[J^T87\V M".3^\H;\Q7Q;XQ<:S\4-7$.<7&J/&G_?S:*^TXD\N)$_NJ!0`ZBBB@`HHHH` M****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`H MHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`*YWQYHI\ M0>!=9TQ`#)-;,8P1_&OS+^H%=%10!\E?`O6$TGXFVL4K%4OHGM?^!'#+^J@? MC7UK7R#\3O#UQX$^)4D]DIBMY)A?6+CH/FR0/]ULC'IBOJ;PKX@M_%/ABPUF MV(V7,09E'\#CAE_`@B@#8HHHSB@#YX^/7P\DBNF\7Z7"6ADPNH(@^XW02?0\ M`^^#WKS#P!XLU;PCXHM[S2HWN&E(BEM%!/VA2?NX'?T/8U]?:[XB\/Z-:2C6 M]3LK>)E*O'/(N7!'(V]3D=L5\ZW_`,1?"7A&:Z'PZT)%O)BV=3O%+&,'M$K< M@?7'N#0![+X]^)NG^"M!CFDC+:O=1!K>PI(ZR8Z`'KZD8'J/DG4M1O=XO+F3?(YY+,?\X`J9FU?Q1K19OM6I:E=/S@&220_Y_*O9?!'A'PM\ M.M1L]0\>:I9Q:Y)AK6Q8^8+;T=]H(W>A/`]SR`#N/@O\/6\(:`VI:C%MU?4% M!=6ZPQ=0GU[G\!VKU"JECJFGZI`)M/O;:[B(R'@E5Q^AJW0`5GZYJD6B:#?Z MI.P$=I`\QS_LC.*T*\9_:$\6+IWANW\.6\@^TZBWF3`'E85/?_>8#_ODT`>. M_#'3)?$WQ3TH3*9`+DWDY[83+Y/U8`?C7V17A_[._A)K+2KSQ/=1;9+W]Q:Y M'/E*?F;Z%@!_P"O<*`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH M`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@` MHHHH`****`"BBB@`HHHH`****`.*^)W@6+QUX6>UC"IJ-L3+9R-Q\^.4)]&Z M?7![5XI\'_'4W@CQ'/X9U[?;6-S-L82\?9;CID^@.,'\#ZU]05Y9\5?A+!XR MB?5M)"0:Y&O.>%N@!PK>C=`&_`^H`.Z\1>'K?Q/IJV<][?V@5Q(LMC<&%P<$ M=1U'/0Y%>7:O\%/$EPQ^P_$'4I(S_P`L[QY#Q]0_/Y5B?#GXM7?A>Y'A/QND MT"VY\J*YF4[X.P20=2OHW;Z=/H&">*Y@2:"5)8G&Y)$8,K#U!'44`?.9_9OU MZ24M+X@L"2RW=KXJEFEE8LQOX2 M[L?=P>3^%>\T4`?.5M^SMXDM)A);^);.!A_'$)%;]*[#1O@UJ\&W^UO'^N31 M_P`4-I.\8/\`P(L?Y5Z[6+XF\5Z/X1TI]0UB[6&,<(@Y>5O[JKW/^3B@"/5M M5TOP-X2:[O;B3[)90A%,LA>24@85*OCOXJ$=K$;71K9\+N_U5LI_B8_Q2$=A^@R:^A?! M_A#3/!>@Q:7ID?`^:69@-\S]V8_T["@#7L+&VTVPM[&SA6&VMXQ''&HX50,` M58HHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`" MBBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`** M**`"BBB@`HHHH`****`.5\9?#W0/'%J$U2VVW*#$5W#A94]L]Q['(KRJ'PK\ M3/A5,S>')UUW102S6N"<#.3^[SE3[H37O]%`'DNB_'S09I/LOB*QO-$O%P'$ MD9D0'\!N'XK7=:?XZ\*:I'OL_$6FR#T-PJM^3$&M'4]#TG68Q'JFFVEZ@Z"X MA5\?3(XKD[SX->`KTY;0(XCZP32)^@;%`'4MXAT5%W-K&GJOJ;E!_6L'5?BG MX)TR?F*]Q@@AMH5AMXHXHE&%2-0JCZ`5)0! M3TO2K#1;"*PTVTBM;6(82*)<`>_N?[XJ:)'CIJT? MZ2"OM.@`KQ;X@?&C5_!7C2\T6+2K.ZMXTC>)W9E;YE!.<'!YSZ5[37RE^T`H M'Q/D([V<)/ZT`?2/@W6;GQ#X0TO6+N...>\@$K)$#M7)/`R2:W*YGX>1>1\. M?#J?]0^$_FH/]:Z:@#Y\UOX_:]HOB;5-*.CZ?.EI=RP1L"ZL0K$#/)YXI7^/ M?BM%RW@Q5]R)-?#[XO:YXQ\;1:->Z7 M9V-N8))3@/YA*C@`DX_3M7LM1M!$\BR-$AD3[KE1E?H>U24`%9/B?7(?#?AG M4=8GQMM(&D"DXW-CY5_$X'XUK5XC^T+K\IL=+\)V8+W%_*)I$7J5!PB_BW_H M-`&I\'_BGJ'CB]U'3]92T2[AC6:#R%*;TSAL@D\@E?SKUJOC#P+K%QX&^)%G M/>*T)M[DVMY&>JJ3L<'Z=?PK[/!R,T`%NKKS[XVIO\`A-K'^R83_P"14H`POAG\7M3\>^*GTNXTRUM(([5Y MRT;,S$AE`'/`'S&O7J^8?V/-0?\`NZ<__HQ*^GJ`.?\`&^MW/AOP7JFL M6:Q-<6D7F(LP)4GJN,@_A3@`HP``/04`?.DO[1VNV[F.?PU:1OC.UY'4_D:5OVA?%#1!XO"]J% M89#$2L"/7M7-_'X8^*$WO:0_R-?17P\`'PY\.`?]`Z#_`-`%`'%?"CXGZWX[ MUW4++5+6RMH[:V$JK`CAB2P'.YCQ7JEW*T-G/*F"Z1LPSTR!FG""%9C,(HQ* M1MWA1NQZ9]*2Y7?:S)_>1A^E`'@?A[X_:[KGB#2=).C:?&;NZB@DE5G.%9@& M(&>#CW-?0-?%WPSC!^*'A]#VOD/Y'/\`2OM&@`KQ/Q[\:]7\&>--0T2+2K*Y MAA$;12.S*V&16YQP>2?2O;*^2OCNNWXK7Y_O00'_`,A@?TH`^GO"NJSZYX4T MK5;F-(Y[RUCG=(P0JEAG`SVYK"^)GBG5_!OAN/6]+M;>ZBAF"744P;[C,-@=^M:O@90G@'P\H[:=;_^BUJUXFT:/Q#X9U+2)!Q=V[Q@^C$?*?P.#0!Y MM\,/B_?>.O%5QI5]86MI&+4S1>46+%E8`@DGT/IVKUZOC/X:ZB_AOXI:1)XBVK"D@)5G9@!G!'')/X M5R'PG^*M]X]U;4;'4K2TMI((4EA$&[YAG#9R3W*UA?M':PPTW1=`A+&2YF:X M=5[A1M4?B6/Y5Y?\(M5?0/BEI8E!C$\K6'_M(ZOY.@Z/I"GFYN&N''LBX M'ZO^E`'6?"SQYK/C^&_O[RPMK*QMV6&(1;F,DAY8Y/8#;QC^*O1*Y+X:>'1X M8\`:58,H$[1>?/[R/\Q_+('X5UM`&-XLU^+POX5U'69=I%K"612?O/T5?Q8@ M5P/P?^*%_P".9]2L=82U2\MU66'R%*ATZ-P2>0$+$,]Q? M2B:2->K#.V-?Q;)_`5Y)\/M9F\$?$NSEO`8A%<-9WB'^%2=C9^AY_"@#[,KA M_B9XHU[P9HL6N:5:6MY9Q/LO(9E; MQ"6VN8VBE0]U(P:`/(_AU\:[KQCXQ31M0T^ULXYX6,!B9BQD7G!)/3:&[=17 MLU?$^M:9J7PZ\?/`K%;K3KE9K>4CB10=R-]".OXBOL7P[K=KXD\/V.KV9S!= M1"0#/W3W4^X.1^%`%;QCXBB\*>$]1UJ0*QMHB8T8X#R'A5_$D5P_PR^(WB/X MA:C,TNEV=EIEHO[^9-[-)(?NHN3@=R>O&/6N8^/NO7&J:KI/@C3`99Y76::- M#DL[';&A_,G\17K/@?PI;>#/"EGH\&UG1=]Q*/\`EK*?O-_0>P%`%KQ+XFTS MPGHLNJZM/Y5NF%``RSL>BJ.Y->/1_%_Q[XKGE;P=X21[.,[?,F1I#^+950?; MFL3]H_5KB7Q1IFD;R+:WM//"YX+NS`D_@@_,U[IX'LK'3_`^BP:<$^S?8XW5 ME_C+*"6/N22:`/'8_COXI\.ZG]B\7^&$1NI$:O!(!Z@-D,/R^M>ZZ1J<.M:/ M9ZG;I*D-U$LT:RKM8*PR,BN>^(/@.T\?:''8SRK;W$,JR0W/E[BG]X8R."/? MT/:NKBB2&%(HU"HBA5`[`=*`'T444`%%%%`!1110`4444`%%%%`!1110!\1Z M;JL?A[XAQ:K+$\L=CJ)F9$(!8*^<"O"ACP+X?'_4.M_\`T6M;M8O@ M]=G@G05SG&G6_P#Z+6MJ@#XP\=R+;_%G6YGSLCU1W;`YP'R:]Z/[0?@D#A=3 M/TMA_P#%5X1XVC6?XP:O$X!1]696!Z$%\&OJ!_ACX(<8/AC3?PA`_E0!7\%? M$S1_'E_>6VDVUZBVD:O))<(J@[B0``&/H:[2N?T#P3X=\+7EQ=:)IJ67IBDV7=]_HD&#S\P^8CZ+NY]<5XCX'L?BIH6D&Y\*Z9(E MGJ`6;S?*A;S``0I^?G')_.@"7X^>&1HWCD:I#'MMM5C\TD#`$J\./Q^5O^!& MO:?/(^ZZM1]DN,]=R``$_5=I^I->(>,K#XM>(M&)\2Z5++9V M6ZXWB&%3&`#D_)SC'4>U7/V>?$W]G>*;K09I,0:C'OB#'@2ISQ]5S^0H`^FZ MX+XT#/PFUS_=B_\`1J5WM<%\9_\`DDVN?[L7_HU*`/(_V;A_Q6FJG_J''_T8 ME?3-?,_[-W_(YZK_`-@\_P#HQ*^F*`"BBB@#Y1^/_P#R4^7_`*](?Y&OHKX? M`CX=>'`?^@=!_P"@"OG7X_?\E0E_Z](?Y&OHSP#_`,D\\._]@Z#_`-`%`'14 MU_\`5M]#3J:_^K;Z&@#XA\,:U%X;\;V.L30O+%9W7F-&A`+`9X&:]W'[27A[ M'S:+J@/L8S_[-7BG@.SM=3^)FD6EY!'<6L][MDBD&5=>>"*^JQ\-O!0''A?2 M_P`;=30!P!_:2\.]M%U7_P`A_P#Q5>*?$?Q7;>-/&,^M6EO+;PR1QH(Y2-WR MK@].*^JF^&O@INOA?2_PMU%?,OQBTC3]#^(UY8:7:16EJD416*(84$H"?UH` M^J?""[?!6@J!C&G6_'_;-:VJR/"O_(GZ)_UX0?\`HM:UZ`/C_P",&COX>^*. MHM"/*2Y9;V$KQC=R3_WV&KZJ\,:NFO>%],U5#Q=6R2'V8CD?GFO&_P!I/12U MIHNN(G^K=[25O8_,G\G_`#K0^#?C&.T^$.J27+;FT'S7VL>J$%U'XMN%`&)J M&[QS^TK!;#+6>CNH;/(`A^9OSD./QKA/BUI$OACXIZA+#E%GE%_`V,/?VB;'1OF MDLM/9(I,=_&C MQ1_PC?P]NXXI-EWJ)^R0XZ@,/G/_`'SD?4B@#SKP/N^(WQVU#Q+(/,T_3F,D M&>@"_)"/KQN^H-/#0T3Q\U_"FVVU6/[0,#@2#AQ^>&_X%3_!%C\5M!T; MS_"VF2I97^V?S/*A;S!CY3\_.,?SI?&NG_%CQ!H_F^)]*EDL[#=/O$4*F,8^ M8_)SC'\J`/=OA5XE'BCX>Z;=.VZYMT^RW'^^@`S^*[3^-=I7S1^SQXH^P>); MOP]/)B'44\R$$\"5!D@?5<_]\BOI>@#QSX^^"AJ_AU/$EI%F]TT8FVCEX">? M^^2<_0M7&?!/XD6OAK3]6TG6+C99Q1/>VV3_`!*/FC7W;@@>N?6OI.:&.X@D MAF19(I%*.C#(92,$'VKXC\<:#%X9\;:MHUNY>&VG(C)Z[2`R@^X!`_"@#V/X M,:)=>+/%NJ?$+6EWN9F2V!&1YA')&>RJ0H^OM7OE9'A;1K7P_P"%]-TNS7;# M;P*HR,%CC+,?!_M$>$+RY:R\46<+RQ01?9KO8,F-02RN1Z MW'K7">`OC'K?@JVCTZ6)-1TI3E8)&*O$#UV/V'L01]*^MG19$9'4,K#!4C(( M]*\M\7?`GPUX@,ESIF='O6YS`NZ%C[Q]O^`D4`;G@_XK>%_&3I;VEV;:_8?\ M>ET-CD^BGHWX'/M7;U\2^+O!VM>`M;6TU%=CY\RVN86.R0`_>4]01QQU%?4O MPI\3W/BSX?V-_>MOO(RUO._]]D.-Q]R,$^Y-`':T444`%%%%`!1110`4444` M%%%%`!2$A5)/0"]%M+^%H+N"RBBEC8@E650"...U;E M`'QEXND!^,&JR=0-9?\`26OLVOE+Q#\+?'FI>,=5U.TT&79-?RS12&:-<@N2 MIY;Z5T1T3X\E-WVVZ^GVR'/\Z`/HOI17@GA/2OB]%XTTI_$,VI-I2S@W'^EH MR%<'J%;D9QVKV_5;BZM-)N[BRM6NKN.)FA@4@&1\?*,D@#G%`'SI\7=1F\HKXMUZQNOA[\2;B&V++)IMX);=L]4R&3\U(S^-?:E>&_&KX::YXI\3: M=J>@6`N6>W,-Q^\5`A4Y4DL1U#$?\!H`]DT?5+?6]&L]4M&W07<*S)SG`(SC MZCI^%<=\:B!\)M:SW$(_\BI4'P=TSQ)X?\,SZ#XBL)+321;8E8`D!P3R2!T%`'D'[-O\`R-^K M_P#7A_[46OI:OE?P[\-?BQX?GEN-&M'T^:5-CL+J$$KG..6/<5MSZ'\>%4YO M+QN/^6=[#G^=`'T;FBO-?A'9>,+.UU4>,A?&[:6,PO=3B4%,'(7#$#GK]17I M5`'R9\>GW?%.[']VWA'_`([G^M?1_P`/FW_#KPX?^H=!_P"@"O%OB=\,_&7B MOX@ZKJFFZ3YEF1&L4C3QIO"QJ#@%L]--%\;Z%J=_HQCM8;I'E83QL8U!ZD!LU]04`%?) M'QV8'XKZB/2&`?\`D-:^MZ^;_B=\,_&/BCXA:MJFFZ.9;-O+6*1IXUWA8U!P M"P/4&@#WGPH0?!VAD=#I\'_HM:UZQ_"EM<67@_1;2\B:*Y@L88I8V()5E0`C MCW%;%`'$_%O1O[;^&6LP+'OE@B%S'Z@QG<:U8K'YDWV@#X7T MOQ#>Z1I6KZ=;$"'5(5AGSU`5PP(_(CZ$U];?"G01X>^'&D6S*%GFB^U3>[2? M-S[@%1^%>%O\$O$[^,W1=*VZ(=1*"8S)Q!O^]MW9QM]J^I418T5$4*J@``=` M*`'5\S_%2_D\??%[3_"]F^8+65;/*\X=B#*WX`8_X#7T5K-S>6FC7EQI]JUW M>I$Q@@4@;WQ\HY(&,XS[5XA\*OAEXGT;XBMK?B2R\H1P22I+YJ2;Y7X/W2>< M,QH`]XM;:&RM(;6W01PPHL<:#HJ@8`_(4Z:*.>%X94#QNI5E/0@C!%/HH`^* MM7MKOX>?$F>.WW++I=Z)(#G[R9W+GZJ1GZU]DZ5J4&L:3::C:L&@NH5F0@YX M89KQ;XS_``RUWQ1XML=3T"P%QYMMY5R?,1`K*>"=Q'4''_`:[+X/Z=XCT'PK M)H7B*PDMY+*8_9I#(KJ\3-=?\=:YJUCHS26LMP3$QGC4NH``(!;/:@#Z4L#NTZU;KF)#^@JQ M532ED32+)9HS'*((PZ'JK;1D5;H`YFX\;Z;:>/K?PC